Beam Therapeutics Inc. (BEAM) Capital expenditures 2019–2025
Beam Therapeutics Inc. (BEAM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$14.9MFY2025 · since FY2019: $12.5M → $14.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.9M | +67.1% |
| FY2024 | $8.9M | -73.5% |
| FY2023 | $33.7M | -31.1% |
| FY2022 | $49.0M | +4.6% |
| FY2021 | $46.8M | +186.2% |
| FY2020 | $16.4M | +30.7% |
| FY2019 | $12.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice